References

1. 1.
   WAN H Y，LI C，LI W，et al Anti-Helicobacter pylori mechanism of Chinese medicine：A review［J］.Chin J Exp Tradit Med Form，2023，29（3）：203-212.
2. 2.
   TSHIBANGU-KABAMBA E， YAMAOKA Y.Helicobacter pylori infection and antibiotic resistance-from biology to clinical implications［J］.Nat Rev Gastroenterol Hepatol，2021，18（9）：613-629.
3. 3.
   TANG X D，WANG F Y，ZHANG S S，et al.Guidelines on Chinese medicine diagnosis and treatment of chronic non-atrophic gastritis， a common disease of the digestive system （primary care Doctor's edition）［J］.Chin J Tradit Chin Med Pharm，2019，34（8）： 3613-3618.
4. 4.
   YUAN X Y， CHEN H Z， GUO J B， et al. Helicobacter pylori study group， Chinese society of gastroenterology， Chinese medical association［J］.J Hebei Med Univ， 2023，44（3）：249-251.
5. 5.
   LAI Y，WEI W，DU Y，et al.Biomaterials for Helicobacter pylori therapy：Therapeutic potential and future perspectives［J］.Gut Microbes，2022，14（1）：2120747.
6. 6.
   CHEY W D，LEONTIADIS G I，HOWDEN C W，et al.Correction：ACG clinical guideline：Treatment of Helicobacter pylori infection［J］.Am J Gastroenterol， 2018，113（7）：1102.
7. 7.
   DU L M，HU S J.Research progress on factors influencing antibiotic resistance of Helicobacter pylori［J］.Chin J Mod Med，2023，33（19）：61-65.
8. 8.
   XU H M，YANG Y F，CHEN L，et al.Progress in the application of sitafloxacin in the eradication therapy of Helicobacter pylori［J］.Her Med，2021，40（8）：1081-1085.
9. 9.
   LI X，XU J，WANG X，et al.Banxia Xiexin decoction treating gastritis mice with drug-resistant Helicobacter pylori and its mechanism［J］.World J Gastroenterol，2023，29（18）：2818-2835.
10. 10.
    ZHANG S Y，LV W L，XU J，et al.Protective mechanism of gastric mucosal injury in Helicobacter pylori-infected rats by Lianpu drink based on NLRP3 inflammatory vesicle pathway［J］.Lishizhen Med Mater Med Res，2023，34（1）：81-84.
11. 11.
    CHAI X，LI X L.Gastric ulcer and analgesic effects of Gaoliangjiang-Xiangfu［J］.Acta Chin Med Pharmacol，2023，51（6）：38-42.
12. 12.
    OUYANG J，SUN F，FENG W，et al.Antimicrobial activity of Galangin and its effects on murein hydrolases of vancomycin-intermediate Staphylococcus aureus （VISA） strain Mu50［J］.Chemotherapy，2018，63（1）：20-28.
13. 13.
    ZHANG B，DAI Y，LIAO Z，et al.Three new antibacterial active diarylheptanoids from Alpinia officinarum［J］. Fitoterapia，2010，81（7）：948-952.
14. 14.
    LIN K，WANG Y，GONG J，et al.Protective effects of total flavonoids from Alpinia officinarum rhizoma against ethanol-induced gastric ulcer in vivo and in vitro［J］.Pharm Biol， 2020，58（1）：854-862.
15. 15.
    MA X，YOU P，XU Y，et al.Anti-Helicobacter pylori-associated gastritis effect of the ethyl acetate extract of Alpinia officinarum Hance through MAPK signaling pathway［J］.J Ethnopharmacol，2020，260：113100.
16. 16.
    MA X Q，YANG M，TU Y J，et al.Study on effective fraction screening of Alpiniae officinarum Rhizoma against H.pylori related gastritis and its inhibitory effect on NF-κB signaling pathway［J］.Chin J Tradit Chin Med Pharm，2021，36（7）：3838-3842.
17. 17.
    LUO X， ZHENG W Y X， ZHAN J T，et al. Screening of anti-Helicobacter pylori gastritis active component of the ethyl acetate extract of Alpinia officinarum Hance based on the knockout strategy［J］.Her Med， 2024，43（9）：1387-1392.
18. 18.
    TANG Q，MA Z，TANG X，et al.Coptisine inhibits Helicobacter pylori and reduces the expression of CagA to alleviate host inflammation in vitro and in vivo［J］.J Ethnopharmacol， 2023，314： 116618.
19. 19.
    MA X Q.Screening for the anti-gastritis active fraction of Alpinia officinarum and studies on its mechanism［D］. Wuhan：Hubei University of Chinese Medicine， 2019.
20. 20.
    QING H Z，NIU X M，XIE X G，et al.Effects of flavonoid components of galangal and greater galangal on PGE₂，EGF and serum IL-8 and TNF-α in gastric tissues of rats with gastric ulcer cold evidence［J］.Lishizhen Med Mater Med Res，2022，33（11）：2612-2614.
21. 21.
    ZHOU J，LI C，TAN L，et al.Inhibition of Helicobacter pylori and its associated urease by palmatine： Investigation on the potential mechanism［J］.PLoS One，2017，12（1）：e0168944.
22. 22.
    CHAVARRÍA-VELÁZQUEZ C O，TORRES-MARTÍNEZ A C，MONTAÑO L F，et al.TLR2 activation induced by H. pylori LPS promotes the differential expression of claudin-4，-6 -7 and -9 via either STAT3 and ERK1/2 in AGS cells［J］.Immunobiology，2018，223（1）：38-48.
23. 23.
    XUN Y，YANG H，KAMINSKA B，et al.Toll-like receptors and Toll-like receptor-targeted immunotherapy against glioma［J］.J Hematol Oncol，2021，14（1）：176.
24. 24.
    ANG T，WANG R，ZHANG J，et al.Mechanism of berberine in treating Helicobacter pylori induced chronic atrophic gastritis through IRF8-IFN-γ signaling axis suppressing［J］.Life Sci，2020，248：117456.
25. 25.
    YOSHIDA N，YOSHIKAWA T，TANAKA Y，et al.A new mechanism for anti-inflammatory actions of proton pump inhibitors--inhibitory effects on neutrophil-endothelial cell interactions［J］.Aliment Pharmacol Ther，2000，14（Suppl 1）：74-81.
26. 26.
    LEE J，LIM J W，KIM H.Astaxanthin inhibits matrix metalloproteinase expression by suppressing PI3K/Akt/mTOR activation in Helicobacter pylori-infected gastric epithelial cells［J］.Nutrients，2022，14（16）： 3427.
27. 27.
    WANG J，DU P L，DONG J Q，et al.Effect of coptisine on PI3K/Akt/mTOR signaling pathway in chronic atrophic gastritis rats［J］.Chin J Exp Tradit Med Form，2024，30（18）：117-124.
28. 28.
    XIE J Y，LIU Y S，ZHU F Y，et al.Neuroprotective effect of ginsenoside Rb₁ on lipopolysaccharide-induced neuroinflammation in mice based on PI3K/Akt signaling pathway［J］.Chin J Exp Tradit Med Form，2024，30（19）：81-89.